TScan Therapeutics, Inc.
NASDAQ:TCRX · NASDAQ Global Market
+$0.02 today
Vol 0.28M · Avg 0.81M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-36.55%
Period High
$2.52
Period Low
$0.85
Latest
$0.92
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Relmada Therapeutics, Inc.
NASDAQ:RLMD
$485.84M
Immunic, Inc.
NASDAQ:IMUX
$140.13M
Vaxart, Inc.
NASDAQ:VXRT
$135.55M
Fortress Biotech, Inc.
NASDAQ:FBIO
$100.49M
Adicet Bio, Inc.
NASDAQ:ACET
$75.91M
XBiotech Inc.
NASDAQ:XBIT
$71.65M
PMV Pharmaceuticals, Inc.
NASDAQ:PMVP
$61.06M
Acrivon Therapeutics, Inc. Common Stock
ACRV
$48.91M
Nutriband Inc.
NTRB
$38.41M
Lite Strategy, Inc.
LITS
$29.06M
What is the latest TCRX filing?
The latest filing shown is 8-K dated May 22, 2026.
How many recent filings does TCRX have?
Intrinsic Alpha currently shows 20 recent filings for TCRX.
Explore More
Continue the stock analysis
Jump to another research area for this company.